SCHEMBL13711270

SCHEMBL13711270

CCOC(=O)[C@@]12C[C@H]1/C=C\CCC(F)(F)CCCC(=O)N1C[C@H](O)C[C@H]1C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8185437 0.89 ADRB3 (0.31) —
SCHEMBL8247433 0.84 — —
SCHEMBL11983990 0.81 CYP3A4 (0.36) —
SCHEMBL13711271 0.80 DPP8 (0.30) —
SCHEMBL14020644 0.80 — —
SCHEMBL6760157 0.79 CTSB (0.31) —
SCHEMBL2837629 0.79 CTSB (0.31) —
SCHEMBL8245129 0.79 CTSB (0.31) —
SCHEMBL2837626 0.79 CTSB (0.31) —
SCHEMBL12730861 0.78 ADRB3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2103623-A2 Novel macrocyclic inhibitors of Hepatitis C virus replication Intermune, Inc. (US) 2009-09-23 — — EP disclosed
Send feedback